Header cover image

Food, Beverage & Tobacco Healthcare Sector

Results

2302

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2302 companies

Journey Medical

Market Cap: US$161.7m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

DERM

US$7.77

7D

12.9%

1Y

115.8%

Accuray

Market Cap: US$161.7m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

ARAY

US$1.64

7D

-5.7%

1Y

3.1%

4D Molecular Therapeutics

Market Cap: US$161.7m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

FDMT

US$3.42

7D

-11.2%

1Y

-86.3%

Voyager Therapeutics

Market Cap: US$161.6m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

VYGR

US$2.82

7D

-17.1%

1Y

-64.8%

Anika Therapeutics

Market Cap: US$161.2m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

ANIK

US$11.14

7D

-6.9%

1Y

-55.0%

Puma Biotechnology

Market Cap: US$160.6m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

PBYI

US$3.44

7D

-5.2%

1Y

-14.4%

LENSAR

Market Cap: US$159.9m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

LNSR

US$13.58

7D

-2.9%

1Y

201.8%

Lineage Cell Therapeutics

Market Cap: US$159.6m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

LCTX

US$0.68

7D

40.6%

1Y

-30.3%

Diaceutics

Market Cap: UK£117.5m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.39

7D

3.3%

1Y

8.6%

Cybin

Market Cap: US$157.1m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

CYBN

US$8.34

7D

19.0%

1Y

-37.3%

Esperion Therapeutics

Market Cap: US$156.6m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

ESPR

US$0.82

7D

-9.8%

1Y

-61.0%

Zentek

Market Cap: CA$215.9m

Engages in the research and development of graphene and related nanomaterials in Canada.

ZEN

CA$2.17

7D

-2.7%

1Y

42.8%

EKF Diagnostics Holdings

Market Cap: UK£113.9m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

EKF

UK£0.25

7D

-2.9%

1Y

-20.8%

Joint

Market Cap: US$153.0m

Operates and franchises chiropractic clinics in the United States.

JYNT

US$10.10

7D

-0.4%

1Y

-36.6%

Race Oncology

Market Cap: AU$237.1m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

RAC

AU$1.37

7D

-0.4%

1Y

-2.8%

Pro-Dex

Market Cap: US$150.8m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

PDEX

US$44.11

7D

-1.0%

1Y

124.3%

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

LDDD

US$4.99

7D

0%

1Y

-3.5%

hVIVO

Market Cap: UK£108.9m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

HVO

UK£0.16

7D

-8.6%

1Y

-39.8%

Cogstate

Market Cap: AU$227.9m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CGS

AU$1.35

7D

0.7%

1Y

9.8%

Alpha Cognition

Market Cap: US$146.4m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

ACOG

US$8.82

7D

-16.6%

1Y

-35.9%

BioAge Labs

Market Cap: US$145.6m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

BIOA

US$3.95

7D

-3.9%

1Y

n/a

Wellgistics Health

Market Cap: US$145.4m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

WGRX

US$2.50

7D

-6.0%

1Y

n/a

Liminatus Pharma

Market Cap: US$144.6m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

LIMN

US$5.07

7D

-19.5%

1Y

-51.8%

TerrAscend

Market Cap: CA$199.6m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

TSND

CA$0.54

7D

0%

1Y

-74.2%

Exagen

Market Cap: US$144.2m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

XGN

US$6.81

7D

14.3%

1Y

251.9%

Rapid Micro Biosystems

Market Cap: US$141.4m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

RPID

US$3.55

7D

11.3%

1Y

342.6%

EUDA Health Holdings

Market Cap: US$139.7m

Operates as a healthcare specialty company.

EUDA

US$3.61

7D

-7.2%

1Y

31.1%

NeOnc Technologies Holdings

Market Cap: US$137.4m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

NTHI

US$7.41

7D

2.2%

1Y

n/a

ALT5 Sigma

Market Cap: US$137.4m

Provides blockchain-powered technologies worldwide.

ALTS

US$8.96

7D

32.0%

1Y

183.5%

Instil Bio

Market Cap: US$137.2m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

TIL

US$24.21

7D

47.2%

1Y

120.8%

Anteris Technologies Global

Market Cap: AU$212.8m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

AVR

AU$5.90

7D

-6.5%

1Y

-69.3%

Eupraxia Pharmaceuticals

Market Cap: CA$189.3m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

EPRX

CA$5.31

7D

-0.9%

1Y

38.6%

Atlantic International

Market Cap: US$136.6m

Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.

ATLN

US$2.34

7D

-7.9%

1Y

n/a

Aclaris Therapeutics

Market Cap: US$136.4m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

ACRS

US$1.27

7D

-5.9%

1Y

21.0%

Kindly MD

Market Cap: US$136.3m

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

NAKA

US$25.03

7D

64.5%

1Y

n/a

Compugen

Market Cap: US$135.6m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

CGEN

US$1.43

7D

1.4%

1Y

-43.3%

Page 19 of 64